Pharma Journalist - Page 42 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

FDA Grants Rare Pediatric Disease Status to Solid Biosciences’ FA Therapy

Final Days to Save £200 on AI in Drug Discovery 2026 Registration – Offer Ends 5 December

Telix Opens First APAC Radiopharmaceutical Manufacturing Site in Japan

Made Scientific, Cellergy Partner to Advance First Mitochondrial Therapy

Novo Nordisk Alzheimer’s Trials Show No Benefit for Semaglutide

FDA Approves First Gene Therapy for Broad SMA Patient Population

Vaximm Enters Talks for Global License of Oral Cancer Therapy

AstraZeneca to Invest $2 Billion in Major Maryland Expansion

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to $2.37 Billion

EU Grants Conditional Approval for Roche’s One-Minute Subcutaneous Lunsumio in Follicular Lymphoma